Summary

The North America CPAP devices market is expected to reach USD 2.31 billion by 2031 from USD 1.39 billion in 2023, growing with a substantial CAGR of 6.7% during the forecast period of 2024 to 2031.
Market Segmentation:
North America CPAP Devices Market Segmentation, By Product Type (CPAP Device and Consumable) Modality (Standalone and Portable), End User (Home Care, Hospitals, Private Clinics, and Others), By Countries (U.S., Canada, and Mexico)– Industry Trends and Forecast to 2031

Overview of North America CPAP Devices Market Dynamics:

Drivers
• Growing increasing awareness and diagnosis of sleep apnea
• Growing elderly population with susceptibility to sleep disorders
• Integration of CPAP devices with telemedicine platforms
Restraints
• High initial costs of CPAP devices and related accessories
• Side effects and discomfort associated with the use of CPAP devices
Opportunities
• Growth in healthcare facilities and services in emerging economies
• Technological advancements and innovations to improve device
• Favorable insurance reimbursement policies and coverage
Challenges
• Stringent and complex regulations across various regions
• Stiff competition from alternative therapies

Market Players:

The key market players operating in the North America CPAP devices market are listed below:
• ResMed
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Limited.
• Drive DeVilbiss International
• BMC
• React Health
• Baird Respiratory
• Transcend, Inc.
• Armstrong Medical Ltd
• Nidek Medical India
• Hunan Beyond Medical Technology Co., Ltd.
• S Technomed (P) Ltd
• BPL Medical Technologies
• Breas Medical AB
• Acare Technology Co., Ltd.
• EVOX Group Of Companies

ページTOPに戻る

Table of Contents

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW 11
1.4 LIMITATIONS 12
1.5 MARKETS COVERED 12
2 MARKET SEGMENTATION 15
2.1 MARKETS COVERED 15
2.2 GEOGRAPHICAL SCOPE 16
2.3 YEARS CONSIDERED FOR THE STUDY 17
2.4 CURRENCY AND PRICING 17
2.5 DBMR TRIPOD DATA VALIDATION MODEL 18
2.6 MULTIVARIATE MODELING 21
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.8 DBMR MARKET POSITION GRID 23
2.9 MARKET END USER COVERAGE GRID 24
2.10 DBMR VENDOR SHARE ANALYSIS 25
2.11 SECONDARY SOURCES 26
2.12 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 33
5 MARKET OVERVIEW 34
5.1 DRIVERS 36
5.1.1 INCREASING AWARENESS AND DIAGNOSIS OF SLEEP APNEA 36
5.1.2 GROWING ELDERLY POPULATION WITH SUSCEPTIBILITY TO SLEEP DISORDERS 37
5.1.3 INTEGRATION OF CPAP DEVICES WITH TELEMEDICINE PLATFORMS 37
5.2 RESTRAINTS 39
5.2.1 HIGH INITIAL COSTS OF CPAP DEVICES AND RELATED ACCESSORIES 39
5.2.2 SIDE EFFECTS AND DISCOMFORT ASSOCIATED WITH THE USE OF CPAP DEVICES 40
5.3 OPPORTUNITIES 41
5.3.1 GROWTH IN HEALTHCARE FACILITIES AND SERVICES IN EMERGING ECONOMIES 41
5.3.2 TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS TO IMPROVE DEVICE FUNCTIONALITY 42
5.3.3 FAVORABLE INSURANCE REIMBURSEMENT POLICIES AND COVERAGE 42
5.4 CHALLENGES 43
5.4.1 STRINGENT AND COMPLEX REGULATIONS ACROSS VARIOUS REGIONS 43
5.4.2 STIFF COMPETITION FROM ALTERNATIVE THERAPIES 44
6 NORTH AMERICA CPAP DEVICES MARKET, BY PRODUCT TYPE 46
6.1 OVERVIEW 47
6.2 CPAP DEVICE 50
6.3 CONSUMABLE 51
7 NORTH AMERICA CPAP DEVICES MARKET, BY MODALITY 52
7.1 OVERVIEW 53
7.2 STANDALONE 56
7.3 PORTABLE 56
8 NORTH AMERICA CPAP DEVICES MARKET, BY END USER 57
8.1 OVERVIEW 58
8.2 HOME CARE 61
8.3 HOSPITALS 61
8.4 PRIVATE CLINICS 62
8.5 OTHERS 62
9 NORTH AMERICA CPAP DEVICES MARKET, BY REGION 63
9.1 NORTH AMERICA 64
9.1.1 U.S. 67
9.1.2 CANADA 69
9.1.3 MEXICO 71
10 NORTH AMERICA CPAP DEVICES MARKET: COMPANY LANDSCAPE 73
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11 SWOT ANALYSIS 74
12 COMPANY PROFILES 75
12.1 RESMED 75
12.1.1 COMPANY SNAPSHOT 75
12.1.2 REVENUE ANALYSIS 75
12.1.3 COMPANY SHARE ANALYSIS 76
12.1.4 PRODUCT PORTFOLIO 76
12.1.5 RECENT DEVELOPMENTS 81
12.2 KONINKLIJKE PHILIPS N.V. 82
12.2.1 COMPANY SNAPSHOT 82
12.2.2 REVENUE ANALYSIS 82
12.2.3 COMPANY SHARE ANALYSIS 83
12.2.4 PRODUCT PORTFOLIO 83
12.2.5 RECENT DEVELOPMENTS 84
12.3 FISHER & PAYKEL HEALTHCARE LIMITED 85
12.3.1 COMPANY SNAPSHOT 85
12.3.2 REVENUE ANALYSIS 85
12.3.3 COMPANY SHARE ANALYSIS 86
12.3.4 PRODUCT PORTFOLIO 86
12.3.5 RECENT DEVELOPMENTS 87
12.4 DRIVE DEVILBISS INTERNATIONAL 88
12.4.1 COMPANY SNAPSHOT 88
12.4.2 COMPANY SHARE ANALYSIS 88
12.4.3 PRODUCT PORTFOLIO 89
12.4.4 RECENT DEVELOPMENTS 90
12.5 BMC. 91
12.5.1 COMPANY SNAPSHOT 91
12.5.2 COMPANY SHARE ANALYSIS 91
12.5.3 PRODUCT PORTFOLIO 92
12.5.4 RECENT DEVELOPMENTS 93
12.6 ACARE TECHNOLOGY CO LTD. 94
12.6.1 COMPANY SNAPSHOT 94
12.6.2 PRODUCT PORTFOLIO 94
12.6.3 RECENT DEVELOPMENTS 94
12.7 ARMSTRONG MEDICAL LTD 95
12.7.1 COMPANY SNAPSHOT 95
12.7.2 PRODUCT PORTFOLIO 95
12.7.3 RECENT DEVELOPMENTS 97
12.8 BPL MEDICAL TECHNOLOGIES 98
12.8.1 COMPANY SNAPSHOT 98
12.8.2 PRODUCT PORTFOLIO 98
12.8.3 RECENT DEVELOPMENTS 99
12.9 BREAS MEDICAL AB 100
12.9.1 COMPANY SNAPSHOT 100
12.9.2 PRODUCT PORTFOLIO 100
12.9.3 RECENT DEVELOPMENTS 100
12.10 EVOX GROUP OF COMPANIES 101
12.10.1 COMPANY SNAPSHOT 101
12.10.2 PRODUCT PORTFOLIO 101
12.10.3 RECENT DEVELOPMENTS 101
12.11 HUNAN BEYOND MEDICAL TECHNOLOGY CO., LTD. 102
12.11.1 COMPANY SNAPSHOT 102
12.11.2 PRODUCT PORTFOLIO 102
12.11.3 RECENT DEVELOPMENT 103
12.12 LOWENSTEIN MEDICAL SE AND CO. KG 104
12.12.1 COMPANY SNAPSHOT 104
12.12.2 PRODUCT PORTFOLIO 104
12.12.3 RECENT DEVELOPMENTS 105
12.13 MORPHEUS HEALTHCARE 106
12.13.1 COMPANY SNAPSHOT 106
12.13.2 PRODUCT PORTFOLIO 106
12.13.3 RECENT DEVELOPMENTS 107
12.14 NARANG MEDICAL LIMITED 108
12.14.1 COMPANY SNAPSHOT 108
12.14.2 PRODUCT PORTFOLIO 108
12.14.3 RECENT DEVELOPMENTS 109
12.15 NIDEK MEDICAL INDIA 110
12.15.1 COMPANY SNAPSHOT 110
12.15.2 PRODUCT PORTFOLIO 110
12.15.3 RECENT DEVELOPMENTS 110
12.16 REACT HEALTH 111
12.16.1 COMPANY SNAPSHOT 111
12.16.2 PRODUCT PORTFOLIO 111
12.16.3 RECENT DEVELOPMENTS 112
12.17 SS TECHNOMED (P) LTD 113
12.17.1 COMPANY SNAPSHOT 113
12.17.2 PRODUCT PORTFOLIO 113
12.17.3 RECENT DEVELOPMENTS 114
12.18 TRANSCEND, INC. 115
12.18.1 COMPANY SNAPSHOT 115
12.18.2 PRODUCT PORTFOLIO 115
12.18.3 RECENT DEVELOPMENTS 116
12.19 THE HOMECARE MEDICAL LTD. 117
12.19.1 COMPANY SNAPSHOT 117
12.19.2 PRODUCT PORTFOLIO 117
12.19.3 RECENT DEVELOPMENTS 118
13 QUESTIONNAIRE 119
14 RELATED REPORTS 122